Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
Wanlu MaWei BaiXueyan WuJiu-Liang ZhaoMeng Tao LiXiaofeng ZengPublished in: Lupus (2020)
Our cases confirmed the efficacy and good follow-up outcomes of low-dose rituximab treatment (100 mg weekly for 4 weeks) for refractory SLE-TTP.